Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis.
Publication
, Journal Article
Garza-Elizondo, AK; Oscherwitz, M; Cervantes-Ramirez, V; Salazar-Marentes, E; Galarza-Delgado, DA; Cardenas-de la Garza, JA
Published in: International journal of rheumatic diseases
October 2024
Duke Scholars
Published In
International journal of rheumatic diseases
DOI
EISSN
1756-185X
ISSN
1756-1841
Publication Date
October 2024
Volume
27
Issue
10
Start / End Page
e15365
Related Subject Headings
- Tumor Necrosis Factor-alpha
- Tumor Necrosis Factor Inhibitors
- Treatment Outcome
- Sarcoma, Kaposi
- Pyrimidines
- Pyrazoles
- Middle Aged
- Male
- Janus Kinase Inhibitors
- Iatrogenic Disease
Citation
APA
Chicago
ICMJE
MLA
NLM
Garza-Elizondo, A. K., Oscherwitz, M., Cervantes-Ramirez, V., Salazar-Marentes, E., Galarza-Delgado, D. A., & Cardenas-de la Garza, J. A. (2024). Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis. International Journal of Rheumatic Diseases, 27(10), e15365. https://doi.org/10.1111/1756-185x.15365
Garza-Elizondo, Angel Kevin, Max Oscherwitz, Valeria Cervantes-Ramirez, Enrique Salazar-Marentes, Dionicio Angel Galarza-Delgado, and Jesus Alberto Cardenas-de la Garza. “Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis.” International Journal of Rheumatic Diseases 27, no. 10 (October 2024): e15365. https://doi.org/10.1111/1756-185x.15365.
Garza-Elizondo AK, Oscherwitz M, Cervantes-Ramirez V, Salazar-Marentes E, Galarza-Delgado DA, Cardenas-de la Garza JA. Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis. International journal of rheumatic diseases. 2024 Oct;27(10):e15365.
Garza-Elizondo, Angel Kevin, et al. “Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis.” International Journal of Rheumatic Diseases, vol. 27, no. 10, Oct. 2024, p. e15365. Epmc, doi:10.1111/1756-185x.15365.
Garza-Elizondo AK, Oscherwitz M, Cervantes-Ramirez V, Salazar-Marentes E, Galarza-Delgado DA, Cardenas-de la Garza JA. Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor-alpha inhibitors in rheumatoid arthritis. International journal of rheumatic diseases. 2024 Oct;27(10):e15365.
Published In
International journal of rheumatic diseases
DOI
EISSN
1756-185X
ISSN
1756-1841
Publication Date
October 2024
Volume
27
Issue
10
Start / End Page
e15365
Related Subject Headings
- Tumor Necrosis Factor-alpha
- Tumor Necrosis Factor Inhibitors
- Treatment Outcome
- Sarcoma, Kaposi
- Pyrimidines
- Pyrazoles
- Middle Aged
- Male
- Janus Kinase Inhibitors
- Iatrogenic Disease